Nonselective: These block both beta-1 and beta-2 receptors (found in the lungs and ... by blocking a chemical called aldosterone. This action reduces the amount of fluid your body retains, which ...

IVIEW Therapeutics Inc., a clinical-stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, today announced positive topline data from its Phase 1/2 clinical ...

While the ongoing Phase I trial is investigating OLX75016 for the treatment of MASH and liver fibrosis, the candidate is also ...

Skye Bioscience, Inc. (NASDAQ:SKYE) is making waves in the biopharmaceutical industry with its innovative approach to obesity treatment. The company's lead candidate, nimacimab, a CB1 negative ...

Diffuse Large B-Cell Lymphoma Companies are involved in targeted therapeutics development with respective active and inactive ...

Part two of this series sees Ravijyot Saggu explore pharmacological management recommendations from the new joint chronic ...

NSYNC’s Lance Bass shares his journey with type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA). The ...

All 12 Quarter Horses have been placed on the Steward's List meaning they cannot run in any licensed jurisdiction in North America until the adjudication process has been finalized. Both trainers were ...

Ravijyot Saggu explores key updates and implications of the new joint chronic asthma guidelines for diagnosis and monitoring.

There was a lot to like in Teva's Q4 report, notably: AUSTEDO and UZEDY had strong years, growing at 34% and 18% to $1.6B ... agent beta-agonist plus steroid in an easy-to-use-dual action inhaler.

YOU might be full to bursting with food but, somehow, there’s always room for dessert. Your cravings for a sugar don’t mean you’re greedy – in fact, wanting a sweet treat ...